spontaneous awakening and breathing trials brad winters md, phd march 14, 2013
TRANSCRIPT
Spontaneous Awakening and Breathing TrialsBrad Winters MD, PhD
March 14, 2013
Spontaneous Awakening and Breathing Trials (SAT &SBT)
2
Spontaneous Awakening and Breathing Trials : VAP Prevention Guidelines
• Does not specifically address SAT and SBT, however supports weaning.
• CDC; MMWR Recomm Rep. 2004;53:1-36
• Recommends use of daily interruption or lightening of sedation to avoid constant heavy sedation and to facilitate and accelerate weaning.
• Does not specifically address SBT. • ATS/IDSA; AJRCCM 2005;171(4):388-416.
3
• Guideline excluded studies that evaluated SAT and SBT.• Canadian VAP Prevention Guidelines; J Crit Care
2008;23(1):138-147.
• Recommends the use of combining a daily assessment of readiness wean and daily sedation interruption.
• SHEA; ICHE 2008;29:S31-S40.
4
Spontaneous Awakening and Breathing Trials : VAP Prevention Guidelines
5
Spontaneous Awakening Trials
Population• Medical ICU patients on mechanical ventilation
Intervention (RCT)• Control group: no interruption (N= 68) • Rx group: daily interruption (N= 60) sedation held
daily until the patients were awake and could follow instructions or uncomfortable or agitated.
• All patients received an infusion of morphine for analgesia.
Kress et al. NEJM 2000; 342:1471-77
6
Spontaneous Awakening Trials
Outcomes• 2.4 day reduction duration mechanical ventilation
– 33% relative risk reduction• 3.5 day reduction ICU length of stay
– 35% relative risk reduction • Hospital length of stay unchanged: control group 16.9
days (8.5-26.6 days) compared to rx group 13.3 days (7.3-20.0 days).
Kress et al. NEJM 2000; 342:1471-77
7
Spontaneous Breathing Trials
Population• Adult medical and coronary ICU patients on
mechanical ventilation (n=300)
Intervention (RCT)• Control group: daily screening (RSBI*) (n=151)• Experimental group: daily screening (RSBI) followed
by 2-hour SBT (n=149) if they passed the screening test
• Physicians were notified when their patients successfully completed the trial of spontaneous breathing.
*RSBI: rapid shallow breathing index Ely et al. NEJM 1996; 335:1864-69.
8
Spontaneous Breathing Trial (SBT)
• Patient passes SBT safety screen• Ventilatory support is removed and the patient is
allowed to breathe through either a T-tube circuit or a ventilatory circuit using “flow triggering” (rather than triggering by pressure) with a continuous positive airway pressure of 5 cm of water.
• No changes are required in the fraction of inspired oxygen or the level of positive end-expiratory pressure.
9
Spontaneous Breathing Trials
Outcomes• 1.5 day reduction duration mechanical ventilation
– 25% relative risk reduction
• 1.0 day reduction ICU length of stay– Not statistically significant
• Reductions total ICU costs
• Reductions in complications including reintubation
Ely et al. NEJM 1996; 335:1864-69.
10
Treatment protocol
Girard et al. Lancet 2008; 371: 126–34
11
ABC Trial: Awakening and Breathing Controlled trial
Population• 336 ICU patients on mechanical ventilation• Four tertiary-care hospitals
Intervention (RCT)• Control group: sedation per usual plus daily SBT
(n=168)• Rx group: daily SAT followed by SBT (n=168) All
patients received an infusion of morphine for analgesia.
Girard et al. Lancet 2008; 371: 126–34
12
ABC Trial: Awakening and Breathing Controlled trial
• 3.1 increased days without mechanical ventilation– 21% relative risk increase
• 3.8 day reduction ICU length of stay– 29% relative risk reduction
• 4.3 day reduction hospital length of stay– 22% relative risk reduction
• Number needed to treat (NNT) = 7.4 for one life saved
Girard et al. Lancet 2008; 371: 126–34
13
Practical SAT
• The SAT consists of two parts,– a safety screen and– the trial.
• The safety screen attempts to assure the trials will not be used when contraindicated. Patients pass the screen unless:
14
The Safety Screen
• Sedation for active seizures or alcohol withdrawal
• Already receiving escalating doses of sedative for agitation
• Receiving neuromuscular blockers• Active myocardial ischemia in prior 24
hours• Evidence of increased ICP
15
If patient passes the safetyscreenAwakening Trial
• All sedatives and analgesics used for sedation are stopped. Analgesics used for pain are continued.
• A patient passes the SAT if awake and can do 3 of 4 simple tasks on request: open eyes, look at caregiver, squeeze hand or stick out their tongue.
• OR
16
If patient passes the safetyscreen
• can go ≥ 4 hrs w/o– sustained anxiety– Agitation or pain– RR of 35 for >= 5 minutes– SpO2 < 88% for >=5 minutes
– an acute cardiac dysrhythmia– ≥ 2 signs of respiratory distress
• Tachycardia, bradycardia, use of accessory muscles, abdominal paradox, diaphoresis, obvious distress
17
SAT Failure
• If a patient fails the SAT, sedatives are restarted at one half the prior dosage and titrated up as needed.
18
SAT Success?
• Maintain adequate oxygenation (SpO2 >=88% on an F1O2 of ≤50% and a PEEP ≤8 cm H2O)
• any spontaneous inspiratory effort in a 5-min period
• no agitation• no significant use of pressors or
inotropes• no evidence of increased ICP
19
SAT successSBT
• Patient breathes through either a T-tube circuit of a ventilatory circuit with CPAP of 5cm H2O or pressure support ventilation of less than 7cm H2O.
• Typically FIO2 is ≤50% and PEEP≤8
20
SBT success?
• Patients pass the trial if they don’t develop any of the same criteria as for the SAT for 120m
• If they pass, the prescriber is notified for extubation order.